Catalyst Wire Dossier Catalyst Wire Dossier

XERAVA

eravacycline · Tetraphase Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for XERAVA, covering 2018-08-27 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia [Phase 2]

See pricing